Excellent. The results still looking very very promising.
"The exact degree of survival benefit the drug combination is providing will require a placebo-controlled study."
I expect we will see this very soon.
What is very reassuring is that there are quite a few authors in common between our little LUPIN study and the big phase 2 TheraP study of LuPSMA that has reported updated results in the same conference.
https://meetinglibrary.asco.org/record/195203/abstract
Someone braver and smarter than me could probably wade in and try and make some interesting comparisons between the LUPIN and LuPSMA-only results in PSA-PFS, overall survival etc.
Ann: LuPIN Survival Outcome Confirmed by Conference Presentation, page-4
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
